BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26288613)

  • 1. Cyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Pathology.
    Grenacher L; Strauß A; Bergmann F; Birdsey M; Mayerle J
    Viszeralmedizin; 2015 Feb; 31(1):31-7. PubMed ID: 26288613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of microcystic, elongated, and fragmented glandular-like features in intraductal papillary mucinous neoplasm of the pancreas.
    Park JY; Lee JH; Song KB; Hwang DW; Kim KR; Kim SC; Hong SM
    Hum Pathol; 2018 Aug; 78():18-27. PubMed ID: 29410139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal Papillary Mucinous Neoplasm of Pancreas.
    Machado NO; Al Qadhi H; Al Wahibi K
    N Am J Med Sci; 2015 May; 7(5):160-75. PubMed ID: 26110127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
    Srinivasan N; Koh YX; Goh BKP
    Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
    Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
    Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
    Adsay NV; Conlon KC; Zee SY; Brennan MF; Klimstra DS
    Cancer; 2002 Jan; 94(1):62-77. PubMed ID: 11815961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary mucinous neoplasms of the pancreas: Cytologic-histologic correlation study and evaluation of the cytologic accuracy in identifying high-grade dysplasia/invasive adenocarcinoma.
    Serinelli S; Khurana KK
    Cytojournal; 2024; 21():6. PubMed ID: 38343764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms.
    Adsay NV; Longnecker DS; Klimstra DS
    Semin Diagn Pathol; 2000 Feb; 17(1):16-30. PubMed ID: 10721804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
    Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
    Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
    Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
    Anand N; Sampath K; Wu BU
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):913-21; quiz e59-60. PubMed ID: 23416279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E
    Yip-Schneider MT; Carr RA; Wu H; Schmidt CM
    J Am Coll Surg; 2017 Oct; 225(4):481-487. PubMed ID: 28739154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.